-
1
-
-
77958614232
-
Hepatitis C treatment: current and future perspectives
-
Munir S, Saleem S, Idrees M, Tariq A, Butt S, et al. (2010) Hepatitis C treatment: current and future perspectives. Virol J 7: 296.
-
(2010)
Virol J
, vol.7
, pp. 296
-
-
Munir, S.1
Saleem, S.2
Idrees, M.3
Tariq, A.4
Butt, S.5
-
2
-
-
1842480410
-
Host factors and failure of interferon-alpha treatment in hepatitis C virus
-
Gao B, Hong F, Radaeva S, (2004) Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology 39: 880-890.
-
(2004)
Hepatology
, vol.39
, pp. 880-890
-
-
Gao, B.1
Hong, F.2
Radaeva, S.3
-
3
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
-
(2009)
Nature
, vol.461
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.J.3
Simon, J.S.4
Shianna, K.V.5
-
4
-
-
70349548852
-
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
-
Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
-
(2009)
Nat Genet
, vol.41
, pp. 1100-1104
-
-
Suppiah, V.1
Moldovan, M.2
Ahlenstiel, G.3
Berg, T.4
Weltman, M.5
-
5
-
-
70349533037
-
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
-
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 41: 1105-1109.
-
(2009)
Nat Genet
, vol.41
, pp. 1105-1109
-
-
Tanaka, Y.1
Nishida, N.2
Sugiyama, M.3
Kurosaki, M.4
Matsuura, K.5
-
6
-
-
70349966196
-
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
-
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
-
(2009)
Nature
, vol.461
, pp. 798-801
-
-
Thomas, D.L.1
Thio, C.L.2
Martin, M.P.3
Qi, Y.4
Ge, D.5
-
7
-
-
79953173221
-
Boceprevir for untreated chronic HCV genotype 1 infection
-
Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, et al. (2011) Boceprevir for untreated chronic HCV genotype 1 infection. The New England journal of medicine 364: 1195-1206.
-
(2011)
The New England Journal of Medicine
, vol.364
, pp. 1195-1206
-
-
Poordad, F.1
McCone Jr., J.2
Bacon, B.R.3
Bruno, S.4
Manns, M.P.5
-
8
-
-
79959381354
-
Telaprevir for retreatment of HCV infection
-
Zeuzem S, Andreone P, Pol S, Lawitz E, Diago M, et al. (2011) Telaprevir for retreatment of HCV infection. The New England journal of medicine 364: 2417-2428.
-
(2011)
The New England Journal of Medicine
, vol.364
, pp. 2417-2428
-
-
Zeuzem, S.1
Andreone, P.2
Pol, S.3
Lawitz, E.4
Diago, M.5
-
9
-
-
84872616595
-
ELECTRON: Once daily PSI-7977 plus RBV in HCV GT1/2/3 [abstract 1113]
-
Barcelona, Spain: EASL
-
Gane EJS, C.A.; Hyland, R.H.; Sorensen, R.D; Symonds, W.T.; Hindes, R.G. (2012) ELECTRON: Once daily PSI-7977 plus RBV in HCV GT1/2/3 [abstract 1113]. Program and abstracts of the 46th Annual Meeting of the European Association for the Study of the Liver. Barcelona, Spain: EASL.
-
(2012)
Program and abstracts of the 46th Annual Meeting of the European Association for the Study of the Liver
-
-
Gane, E.J.S.C.A.1
Hyland, R.H.2
Sorensen, R.D.3
Symonds, W.T.4
Hindes, R.G.5
-
10
-
-
77951576906
-
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
-
Askarieh G, Alsio A, Pugnale P, Negro F, Ferrari C, et al. (2010) Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology. 51: 1523-1530.
-
(2010)
Hepatology
, vol.51
, pp. 1523-1530
-
-
Askarieh, G.1
Alsio, A.2
Pugnale, P.3
Negro, F.4
Ferrari, C.5
-
11
-
-
23744481169
-
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
-
Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, et al. (2005) Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood. 106: 1175-1182.
-
(2005)
Blood
, vol.106
, pp. 1175-1182
-
-
Butera, D.1
Marukian, S.2
Iwamaye, A.E.3
Hembrador, E.4
Chambers, T.J.5
-
12
-
-
33144462713
-
Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
-
Diago M, Castellano G, Garcia-Samaniego J, Perez C, Fernandez I, et al. (2006) Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut. 55: 374-379.
-
(2006)
Gut
, vol.55
, pp. 374-379
-
-
Diago, M.1
Castellano, G.2
Garcia-Samaniego, J.3
Perez, C.4
Fernandez, I.5
-
13
-
-
79952097683
-
Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B Related Single Nucleotide Polymorphisms
-
Lagging M, Askarieh G, Negro F, Bibert S, Soderholm J, et al. (2011) Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B Related Single Nucleotide Polymorphisms. PLoS ONE 6: e17232.
-
(2011)
PLoS ONE
, vol.6
-
-
Lagging, M.1
Askarieh, G.2
Negro, F.3
Bibert, S.4
Soderholm, J.5
-
14
-
-
33845662689
-
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
-
Lagging M, Romero AI, Westin J, Norkrans G, Dhillon AP, et al. (2006) IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44: 1617-1625.
-
(2006)
Hepatology
, vol.44
, pp. 1617-1625
-
-
Lagging, M.1
Romero, A.I.2
Westin, J.3
Norkrans, G.4
Dhillon, A.P.5
-
15
-
-
33749017951
-
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
-
Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, et al. (2006) Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 194: 895-903.
-
(2006)
J Infect Dis
, vol.194
, pp. 895-903
-
-
Romero, A.I.1
Lagging, M.2
Westin, J.3
Dhillon, A.P.4
Dustin, L.B.5
-
16
-
-
79960382329
-
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
-
Bochud PY, Bibert S, Negro F, Haagmans B, Soulier A, et al. (2011) IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. J Hepatol.
-
(2011)
J Hepatol
-
-
Bochud, P.Y.1
Bibert, S.2
Negro, F.3
Haagmans, B.4
Soulier, A.5
-
17
-
-
0035254238
-
Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in human thymus
-
Romagnani P, Annunziato F, Lazzeri E, Cosmi L, Beltrame C, et al. (2001) Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in human thymus. Blood 97: 601-607.
-
(2001)
Blood
, vol.97
, pp. 601-607
-
-
Romagnani, P.1
Annunziato, F.2
Lazzeri, E.3
Cosmi, L.4
Beltrame, C.5
-
18
-
-
63349107684
-
Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis
-
Denney H, Clench MR, Woodroofe MN, (2009) Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and-9: implications for chemotaxis. Biochem Biophys Res Commun 382: 341-347.
-
(2009)
Biochem Biophys Res Commun
, vol.382
, pp. 341-347
-
-
Denney, H.1
Clench, M.R.2
Woodroofe, M.N.3
-
19
-
-
0035895070
-
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
-
Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, et al. (2001) Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554-3561.
-
(2001)
Blood
, vol.98
, pp. 3554-3561
-
-
Proost, P.1
Schutyser, E.2
Menten, P.3
Struyf, S.4
Wuyts, A.5
-
20
-
-
78650962504
-
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
-
Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, et al. (2011) Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest 121: 308-317.
-
(2011)
J Clin Invest
, vol.121
, pp. 308-317
-
-
Casrouge, A.1
Decalf, J.2
Ahloulay, M.3
Lababidi, C.4
Mansour, H.5
-
21
-
-
0027270023
-
The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity
-
Tanaka T, Kameoka J, Yaron A, Schlossman SF, Morimoto C, (1993) The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proceedings of the National Academy of Sciences of the United States of America 90: 4586-4590.
-
(1993)
Proceedings of the National Academy of Sciences of the United States of America
, vol.90
, pp. 4586-4590
-
-
Tanaka, T.1
Kameoka, J.2
Yaron, A.3
Schlossman, S.F.4
Morimoto, C.5
-
22
-
-
0035834010
-
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
-
Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, et al. (2001) CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc Natl Acad Sci U S A 98: 12138-12143.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 12138-12143
-
-
Ishii, T.1
Ohnuma, K.2
Murakami, A.3
Takasawa, N.4
Kobayashi, S.5
-
23
-
-
0035892903
-
Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs
-
Ohnuma K, Munakata Y, Ishii T, Iwata S, Kobayashi S, et al. (2001) Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs. J Immunol 167: 6745-6755.
-
(2001)
J Immunol
, vol.167
, pp. 6745-6755
-
-
Ohnuma, K.1
Munakata, Y.2
Ishii, T.3
Iwata, S.4
Kobayashi, S.5
-
24
-
-
33750691709
-
PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion
-
Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, et al. (2006) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. Journal of virology 80: 11398-11403.
-
(2006)
Journal of Virology
, vol.80
, pp. 11398-11403
-
-
Urbani, S.1
Amadei, B.2
Tola, D.3
Massari, M.4
Schivazappa, S.5
-
25
-
-
0037105567
-
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection
-
Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447-3458.
-
(2002)
J Immunol
, vol.169
, pp. 3447-3458
-
-
Wedemeyer, H.1
He, X.S.2
Nascimbeni, M.3
Davis, A.R.4
Greenberg, H.B.5
-
26
-
-
44849113503
-
Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences
-
Golden-Mason L, Klarquist J, Wahed AS, Rosen HR, (2008) Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J Immunol 180: 3637-3641.
-
(2008)
J Immunol
, vol.180
, pp. 3637-3641
-
-
Golden-Mason, L.1
Klarquist, J.2
Wahed, A.S.3
Rosen, H.R.4
-
27
-
-
0029151623
-
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
-
Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, et al. (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
-
(1995)
Lancet
, vol.346
, pp. 1006-1007
-
-
Diepolder, H.M.1
Zachoval, R.2
Hoffmann, R.M.3
Wierenga, E.A.4
Santantonio, T.5
-
28
-
-
34848870230
-
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)
-
Pilli M, Zerbini A, Penna A, Orlandini A, Lukasiewicz E, et al. (2007) HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology 133: 1132-1143.
-
(2007)
Gastroenterology
, vol.133
, pp. 1132-1143
-
-
Pilli, M.1
Zerbini, A.2
Penna, A.3
Orlandini, A.4
Lukasiewicz, E.5
-
29
-
-
21844477610
-
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C
-
Zeuzem S, Pawlotsky JM, Lukasiewicz E, von Wagner M, Goulis I, et al. (2005) International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. J Hepatol. 43: 250-257.
-
(2005)
J Hepatol
, vol.43
, pp. 250-257
-
-
Zeuzem, S.1
Pawlotsky, J.M.2
Lukasiewicz, E.3
von Wagner, M.4
Goulis, I.5
-
30
-
-
24644507185
-
Genotyping of hepatitis C virus by Taqman real-time PCR
-
Lindh M, Hannoun C, (2005) Genotyping of hepatitis C virus by Taqman real-time PCR. J Clin Virol 34: 108-114.
-
(2005)
J Clin Virol
, vol.34
, pp. 108-114
-
-
Lindh, M.1
Hannoun, C.2
-
31
-
-
79959587024
-
IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
-
Lindh M, Lagging M, Arnholm B, Eilard A, Nilsson S, et al. (2011) IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1. J Viral Hepat 18: e325-331.
-
(2011)
J Viral Hepat
, vol.18
-
-
Lindh, M.1
Lagging, M.2
Arnholm, B.3
Eilard, A.4
Nilsson, S.5
-
32
-
-
84874229764
-
-
eBioscience, Access. Available
-
eBioscience. Human sCD26 Platinum ELISA.Access. Available: http://www.bendermedsystems.org/bm_products/MAN/235CE.pdf. Accessed 2012 Dec 10.
-
Human sCD26 Platinum
-
-
-
33
-
-
84874279004
-
-
Access. Available
-
Systems RD. Human CXCL10/IP-10 Immunoassay.Access. Available: http://www.rndsystems.com/pdf/dip100.pdf. Accessed 2012 Dec 10.
-
Human CXCL10/IP-10 Immunoassay
-
-
-
34
-
-
28444473437
-
Los alamos hepatitis C immunology database
-
Yusim K, Richardson R, Tao N, Dalwani A, Agrawal A, et al. (2005) Los alamos hepatitis C immunology database. Appl Bioinformatics 4: 217-225.
-
(2005)
Appl Bioinformatics
, vol.4
, pp. 217-225
-
-
Yusim, K.1
Richardson, R.2
Tao, N.3
Dalwani, A.4
Agrawal, A.5
-
35
-
-
0029028843
-
A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests
-
Greiner M, Sohr D, Gobel P, (1995) A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 185: 123-132.
-
(1995)
J Immunol Methods
, vol.185
, pp. 123-132
-
-
Greiner, M.1
Sohr, D.2
Gobel, P.3
-
36
-
-
0029075943
-
Two-graph receiver operating characteristic (TG-ROC): a Microsoft-EXCEL template for the selection of cut-off values in diagnostic tests
-
Greiner M, (1995) Two-graph receiver operating characteristic (TG-ROC): a Microsoft-EXCEL template for the selection of cut-off values in diagnostic tests. J Immunol Methods 185: 145-146.
-
(1995)
J Immunol Methods
, vol.185
, pp. 145-146
-
-
Greiner, M.1
-
37
-
-
79953325779
-
Novel aspects of cellular action of dipeptidyl peptidase IV/CD26
-
Ansorge S, Nordhoff K, Bank U, Heimburg A, Julius H, et al. (2011) Novel aspects of cellular action of dipeptidyl peptidase IV/CD26. Biol Chem 392: 153-168.
-
(2011)
Biol Chem
, vol.392
, pp. 153-168
-
-
Ansorge, S.1
Nordhoff, K.2
Bank, U.3
Heimburg, A.4
Julius, H.5
-
38
-
-
0034948257
-
Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C
-
Firneisz G, Lakatos PL, Szalay F, (2001) Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C. Scand J Gastroenterol. 36: 877-880.
-
(2001)
Scand J Gastroenterol
, vol.36
, pp. 877-880
-
-
Firneisz, G.1
Lakatos, P.L.2
Szalay, F.3
-
39
-
-
77951258833
-
Features of responding T cells in cancer and chronic infection
-
Kim PS, Ahmed R, (2010) Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 22: 223-230.
-
(2010)
Curr Opin Immunol
, vol.22
, pp. 223-230
-
-
Kim, P.S.1
Ahmed, R.2
|